Cargando…
In vivo kinetics of early, non-random methylome and transcriptome changes induced by DNA-hypomethylating treatment in primary AML blasts
Despite routine use of DNA-hypomethylating agents (HMAs) in AML/MDS therapy, their mechanisms of action are not yet unraveled. Pleiotropic effects of HMAs include global methylome and transcriptome changes. We asked whether in blasts and T-cells from AML patients HMA-induced in vivo demethylation an...
Autores principales: | Greve, Gabriele, Andrieux, Geoffroy, Schlosser, Pascal, Blagitko-Dorfs, Nadja, Rehman, Usama-Ur, Ma, Tobias, Pfeifer, Dietmar, Heil, Gerhard, Neubauer, Andreas, Krauter, Jürgen, Heuser, Michael, Salih, Helmut R., Döhner, Konstanze, Döhner, Hartmut, Hackanson, Björn, Boerries, Melanie, Lübbert, Michael |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10169639/ https://www.ncbi.nlm.nih.gov/pubmed/37024521 http://dx.doi.org/10.1038/s41375-023-01876-2 |
Ejemplares similares
-
Epigenetic Priming of AML Blasts for All-trans Retinoic Acid-Induced Differentiation by the HDAC Class-I Selective Inhibitor Entinostat
por: Blagitko-Dorfs, Nadja, et al.
Publicado: (2013) -
Induction of cancer testis antigen expression in circulating acute myeloid leukemia blasts following hypomethylating agent monotherapy
por: Srivastava, Pragya, et al.
Publicado: (2016) -
Integrative study of EZH2 mutational status, copy number, protein expression and H3K27 trimethylation in AML/MDS patients
por: Stomper, Julia, et al.
Publicado: (2021) -
Correction to: Integrative study of EZH2 mutational status, copy number, protein expression and H3K27 trimethylation in AML/MDS patients
por: Stomper, Julia, et al.
Publicado: (2021) -
Distinguishing AML from MDS: a fixed blast percentage may no longer be optimal
por: Estey, Elihu, et al.
Publicado: (2022)